Trial intelligence / Profile preview

Bilateral Lumbar Erector Spinae Block in PLIF Surgery

NCT03825198Phase 3Unknown

Start
Aug 2019
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of levobupivacaine in postoperative pain (2 arms). Primary endpoint: 24 hour morphine consumption. Status: unknown.

02

Drugs

levobupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03825198.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03825198.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call